Literature DB >> 10538328

Standard cost lists for healthcare in Canada. Issues in validity and inter-provincial consolidation.

P Jacobs1, N P Roos.   

Abstract

A standard cost list is a listing of recommended costs for a selected group of services. Standard costs are used in economic evaluation studies to eliminate that proportion of cost differences between interventions that are due to cost differences between providers. In this article we provide a summary of cost lists for pharmaceutical economic evaluation purposes which have been developed in 2 provinces in Canada-Alberta and Manitoba. We then assess these 2 lists from 2 different viewpoints. First, we developed criteria for the internal and external validity of costs and, in light of these validity criteria, we assessed how the 2 standard cost lists compared with the 'ideal' measure of long run marginal costs. Second, we identified the criteria for the inter-provincial consolidation of standard cost measures (in order to develop a single, consolidated cost list); in light of these criteria, we assessed whether the degree to which the 2 separate lists could be consolidated. The lists achieved a considerable degree of external validity, but fared less well in terms of internal validity. However, these results depend on the 'ideal' measure of cost which is used. The lists, in the forms which were developed, are not easily consolidated into a single list. Further refined cost data would be needed in order to achieve consolidation.

Mesh:

Year:  1999        PMID: 10538328     DOI: 10.2165/00019053-199915060-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  10 in total

Review 1.  Economic evaluations in the critical care literature: do they help us improve the efficiency of our unit?

Authors:  D K Heyland; P Kernerman; A Gafni; D J Cook
Journal:  Crit Care Med       Date:  1996-09       Impact factor: 7.598

Review 2.  Biases in cost measurement for economic evaluation studies in health care.

Authors:  P Jacobs; J F Baladi
Journal:  Health Econ       Date:  1996 Nov-Dec       Impact factor: 3.046

Review 3.  Costing methods in the Canadian literature on the economic evaluation of health care. A survey and assessment.

Authors:  P Jacobs; J Bachynsky
Journal:  Int J Technol Assess Health Care       Date:  1996       Impact factor: 2.188

4.  Estimating physicians' work for a resource-based relative-value scale.

Authors:  W C Hsiao; P Braun; D Yntema; E R Becker
Journal:  N Engl J Med       Date:  1988-09-29       Impact factor: 91.245

5.  Estimating the cost of outpatient hospital care.

Authors:  P Jacobs; E M Hall
Journal:  Healthc Manage Forum       Date:  1995

6.  Refining a case-mix measure for nursing homes: Resource Utilization Groups (RUG-III).

Authors:  B E Fries; D P Schneider; W J Foley; M Gavazzi; R Burke; E Cornelius
Journal:  Med Care       Date:  1994-07       Impact factor: 2.983

7.  The distinction between cost and charges.

Authors:  S A Finkler
Journal:  Ann Intern Med       Date:  1982-01       Impact factor: 25.391

8.  Do case-mix adjusted nursing home reimbursements actually reflect costs? Minnesota's experience.

Authors:  J A Nyman; R A Connor
Journal:  J Health Econ       Date:  1994-07       Impact factor: 3.883

9.  Economic evaluation and randomised controlled trial of extracorporeal membrane oxygenation: UK collaborative trial. The Extracorporeal Membrane Oxygenation Economics Working Group.

Authors:  T E Roberts
Journal:  BMJ       Date:  1998-10-03
  10 in total
  13 in total

1.  Standardisation of costs: the Dutch Manual for Costing in economic evaluations.

Authors:  Jan B Oostenbrink; Marc A Koopmanschap; Frans F H Rutten
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

2.  Working more productively: tools for administrative data.

Authors:  Leslie L Roos; Ruth-Ann Soodeen; Ruth Bond; Charles Burchill
Journal:  Health Serv Res       Date:  2003-10       Impact factor: 3.402

Review 3.  Introducing economic evaluation as a policy tool in Korea: will decision makers get quality information? : a critical review of published Korean economic evaluations.

Authors:  Kun-Sei Lee; Werner B F Brouwer; Sang-Il Lee; Hye-Won Koo
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

4.  Unit costs of inpatient hospital days.

Authors:  Jan B Oostenbrink; Tineke Buijs-Van der Woude; Michel van Agthoven; Marc A Koopmanschap; Frans F H Rutten
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

5.  A tool for communication with decision-makers: limitations and utilization of studies on cost of illness.

Authors:  Kun Sei Lee
Journal:  Korean J Hepatol       Date:  2011-12

6.  Cost of clinical events in health economic evaluations in Germany: a systematic review.

Authors:  Monika Scheuringer; Narine Sahakyan; Karl J Krobot; Volker Ulrich
Journal:  Cost Eff Resour Alloc       Date:  2012-05-31

7.  The evaluating self-management and educational support in severely obese patients awaiting multidisciplinary bariatric care (EVOLUTION) trial: rationale and design.

Authors:  Raj S Padwal; Arya M Sharma; Miriam Fradette; Susan Jelinski; Scott Klarenbach; Alun Edwards; Sumit R Majumdar
Journal:  BMC Health Serv Res       Date:  2013-08-17       Impact factor: 2.655

8.  The evaluating self-management and educational support in severely obese patients awaiting multidisciplinary bariatric care (EVOLUTION) trial: principal results.

Authors:  Raj S Padwal; Scott Klarenbach; Arya M Sharma; Miriam Fradette; Susan E Jelinski; Alun Edwards; Sumit R Majumdar
Journal:  BMC Med       Date:  2017-03-02       Impact factor: 8.775

Review 9.  Cost transferability problems in economic evaluation as a framework for an European health care and social costs database.

Authors:  Leticia García-Mochón; Joan Rovira Forns; Jaime Espin
Journal:  Cost Eff Resour Alloc       Date:  2021-07-18

10.  Telemonitoring and Protocolized Case Management for Hypertensive Community-Dwelling Seniors With Diabetes: Protocol of the TECHNOMED Randomized Controlled Trial.

Authors:  Raj Padwal; Finlay Aleck McAlister; Peter William Wood; Pierre Boulanger; Miriam Fradette; Scott Klarenbach; Alun L Edwards; Jayna M Holroyd-Leduc; Kannayiram Alagiakrishnan; Doreen Rabi; Sumit Ranjan Majumdar
Journal:  JMIR Res Protoc       Date:  2016-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.